Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(3-Fluorophenyl)-2-(5-methyl-1H-1,2,3,4-tetrazol-1-yl)propanoic acid is a potent activator of GABAA receptors. It has been shown to have high affinity for GABA binding sites and is able to activate the receptor with an EC50 of around 100 nM. It also has no effect on other receptors that are structurally related to GABA, such as glycine and 5HT3 receptors. 3-(3-Fluorophenyl)-2-(5-methyl-1H-1,2,3,4-tetrazol-1-yl)propanoic acid is soluble in DMSO and ethanol.</p>

<p>Versatile small molecule scaffold</p>

<p>1-Phenyl-1,2,4-triazolidine-3,5-dione is a molecule that can be used for biological purposes. It has the chemical formula of C6H4N2O3 and a molecular weight of 180.14 g/mol. The hydrogen bonds between the hydroxyl group and the skeleton are strong enough to keep the molecule in shape. The molecule is thermally developable; it can be developed after exposure to heat or light. 1-Phenyl-1,2,4-triazolidine-3,5-dione has been shown to react with silver ions and metal surfaces such as aluminum and titanium oxide. This compound may also be useful for coatings that are reactive to light or heat because it will form a film when exposed to either one.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Bicyclo[4.1.0]heptan-7-ylmethanol is a hydride inhibitor of lactate dehydrogenase, which is an enzyme that catalyzes the conversion of pyruvate to lactate in the liver. Bicyclo[4.1.0]heptan-7-ylmethanol has inhibitory properties against aldehyde dehydrogenase and alcohol dehydrogenase, which are enzymes involved in the metabolism of aldehydes and alcohols respectively. This substance also inhibits mitochondrial monoamine oxidase (MAO), which is an enzyme that breaks down neurotransmitters such as dopamine, norepinephrine, and serotonin. Bicyclo[4.1.0]heptan-7-ylmethanol can be used to inhibit the function of MAO in order to increase levels of these neurotransmitters in the brain, which may be helpful for conditions like depression or Parkinson</p>

<p>1-Benzothiophene-6-carboxylic acid is a nicotinic acetylcholine receptor agonist that has been shown to have high oral bioavailability and efficacy in vivo. It binds to the α7 nicotinic acetylcholine receptor and activates the receptor, leading to increased neurotransmitter release. 1-Benzothiophene-6-carboxylic acid has been shown to be effective in vivo in models of neuropathic pain and Parkinson's disease. This drug also has a low affinity for other receptors, such as muscarinic acetylcholine receptors, which reduces the chance of adverse effects.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>